Sever sepsis after probiotic treatment with Escherichia coli NISSLE 1917.

作者信息

Guenther Katrin, Straube Eberhardt, Pfister Wolfgang, Guenther Albrecht, Huebler Axel

出版信息

Pediatr Infect Dis J. 2010 Feb;29(2):188-9. doi: 10.1097/INF.0b013e3181c36eb9.

DOI:10.1097/INF.0b013e3181c36eb9

PMID:20118747

Abstract

摘要

相似文献

[1]

Sever sepsis after probiotic treatment with Escherichia coli NISSLE 1917.

Pediatr Infect Dis J. 2010-2

[2]

Plasmid-mediated ArmA and RmtB 16S rRNA methylases in Escherichia coli isolated from chickens.

J Antimicrob Chemother. 2009-12

[3]

Lactobacillus sepsis associated with probiotic therapy.

Pediatrics. 2005-1

[4]

Escherichia coli producing KPC-2 carbapenemase: first report in Brazil.

Diagn Microbiol Infect Dis. 2010-11

[5]

Characterization of plasmids encoding CMY-2 AmpC beta-lactamases from Escherichia coli in Canadian intensive care units.

Diagn Microbiol Infect Dis. 2009-9-23

[6]

Dominance of CTX-M-2 and CTX-M-56 among extended-spectrum beta-lactamases produced by Klebsiella pneumoniae and Escherichia coli isolated in hospitals in Paraguay.

J Antimicrob Chemother. 2009-12

[7]

Characteristics of Romanian fluoroquinolone-resistant human clinical Escherichia coli isolates.

Roum Arch Microbiol Immunol. 2008

[8]

Clonal dissemination of highly virulent extended-spectrum beta-lactamase-producing Escherichia coli strains isolated from the urine of non-hospitalised patients in Zagreb region.

Int J Antimicrob Agents. 2008-2

[9]

Prolonged fecal shedding of CTX-M-15-producing Escherichia coli and recurrent sepsis in a patient after cord blood stem-cell transplantation.

Scand J Infect Dis. 2009

[10]

Absence of CTX-M enzymes but high prevalence of clones, including clone ST131, among fecal Escherichia coli isolates from healthy subjects living in the area of Paris, France.

J Clin Microbiol. 2008-12

引用本文的文献

[1]

Selection, Comparative Genomics, and Potential Probiotic Features of Escherichia coli 5C, a pks-Negative Strain Isolated from Healthy Infant Donor Feces.

Probiotics Antimicrob Proteins. 2025-4-16

[2]

Benefits and concerns of probiotics: an overview of the potential genotoxicity of the colibactin-producing Nissle 1917 strain.

Gut Microbes. 2024

[3]

Probiotics Modulate Host Immune Response and Interact with the Gut Microbiota: Shaping Their Composition and Mediating Antibiotic Resistance.

Int J Mol Sci. 2023-9-7

[4]

Emerging issues in probiotic safety: 2023 perspectives.

Gut Microbes. 2023

[5]

Serial passage in an insect host indicates genetic stability of the human probiotic Nissle 1917.

Evol Med Public Health. 2022-2-11

[6]

Invasive Infections Associated with the Use of Probiotics in Children: A Systematic Review.

Children (Basel). 2021-10-16

[7]

Diversity and Adaptations of Strains: Exploring the Intestinal Community in Crohn's Disease Patients and Healthy Individuals.

Microorganisms. 2021-6-15

[8]

Deciphering the interplay between the genotoxic and probiotic activities of Escherichia coli Nissle 1917.

PLoS Pathog. 2019-9-23

[9]

Can probiotics modulate human disease by impacting intestinal barrier function?

Br J Nutr. 2017-1

[10]

Microbial therapeutic interventions.

Semin Fetal Neonatal Med. 2016-12

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

新学期，新优惠

Sever sepsis after probiotic treatment with Escherichia coli NISSLE 1917.

作者信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

推荐工具

Suppr 超能文献

相似文献

引用本文的文献